-
Daily Time-Course of Efficacy of Continuous Subcutaneous Infusion of Foslevodopa/foscarbidopa in Advanced Parkinson’s Disease Patients from a Phase 1b Study
-
De novo impulse control disorder after globus pallidus internus deep brain stimulation in a patient with myoclonus-dystonia syndrome
-
De-novo ß-actin mutation as a cause of seemingly sporadic dystonia-deafness syndrome responsive to deep-brain stimulation
-
Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD
-
Decreased Availability of Adenosine 2A Receptors in the Caudate in Patients with Early Stage Parkinson’s Disease
-
Decreased Regional Cholinergic Signaling in Parkinson’s Disease
-
Deep Brain Stimulation (DBS) for Childhood Onset Dystonia
-
Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test
-
Deep Brain Stimulation as the Only Advanced Therapy Available in the Dominican Rebublic, Report ot Two Cases in Centro Cardio Neuro Oftalmologico Y Transplante (Cecanot)
-
Deep brain stimulation for generalized dystonia
-
Deep Brain Stimulation for medically refractory tremor syndromes
-
Deep Brain Stimulation impact on Social and Occupational Function in Parkinson’s Disease with Early Motor Complications
-
Deep brain stimulation in Parkinson’s disease: Selection criteria, post-surgery improvement and complications
-
Deep brain stimulation in the treatment of camptocormia in Parkinson’s disease
-
Deep brain stimulation in two patients with immunosuppressive therapy
-
Deep brain stimulation lead position impact on parkinsonian non-motor symptoms
-
Deep brain stimulation lead removal in Tourette syndrome: Data from the International Tourette DBS Registry and Database
-
Deep brain stimulation peri-lead edema: Common or uncommon complication?
-
Deep brain stimulation revision from VIM to VIM and PSA severe long-standing refractory ET: case series
-
Deep Brain Stimulation using Asymmetrical Targets in Rapid-onset Dystonia Parkinsonism (RDP)
-
Deep learning approach for Parkinson’s disease classification from facial expressions: A pilot feasibility study
-
Deep learning-based automatic nigrosome 1 segmentation on 3T susceptibility-weighted MRI
-
Deep phenotyping of Parkinson’s disease: a longitudinal study using multiple digital sensors
-
Deficient Balance Mechanisms during Walking in People with Parkinson’s Disease
-
Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease
-
Delayed lesion adverse effects of gamma knife radiosurgical thalamotomy for essential tremor
-
Delayed resolution of hemifacial spasm following suboccipital craniectomy in a patient with Arnold Chiari malformation type I
-
Demographic characteristics of in-hospital deaths among patients with Parkinson’s disease
-
Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson’s disease patients: Evidence from G7 countries
-
Dendritic cells and brain metabolites in Tourette’s
-
Deposition of phosphorylated α-synuclein in the muscularis externa of the gastrointestinal tract in patients with prodromal Parkinson’s disease
-
Depression in Parkinson’s Disease: perspectives from an Australian cohort
-
Depression in patients with Parkinson’s disease
-
Depression in various forms of parkinsonism and striatal hyperkinesis
-
Detecting Lower Extremity Ataxia: Toe-Heel Tap is the Best Screening Tool
-
Detection of alpha-synuclein aggregation from submandibular and esophageal tissue of patients with synucleinopathies
-
Detection of Cognitive Changes in Premanifest Huntington’s disease Using the Repeatable Battery for the Assessment of Neuropsychological Status
-
Determinants of quality of life in a large, online cohort of patients with Parkinson’s disease
-
Determination of freezing of gait with wearable sensors in patients with Parkinson’s disease
-
Determination of non-motor symptoms in Parkinson’s disease in Kazakhstan (on the example of the city of Almaty)
-
Deutetrabenazine for Huntington’s disease chorea—A Single Center’s Experience
-
Deutetrabenazine Reduces Involuntary Movements in Patients Most Severely Impacted by Tardive Dyskinesia in a 3-year Open-Label Extension Trial
-
Developing A Novel Disease-Specific Psychosis Severity Scale in Parkinson’s disease (Psy-PD): A Pilot Study
-
Development and Characterization of an Ultrasensitive Assay Platform for Detection of PD Associated alpha-Synuclein Oligomers in Human Blood
-
Development and validation of a profile of peripheral immune biomarkers for Parkinson’s disease: A multicenter, retrospective study
-
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10)
-
Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials
-
Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage
-
Development of novel treatment strategies for SGCE dystonia using patient-derived induced pluripotent stem cells (iPSCs)
-
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism
-
Diagnostic Demography of the Ataxia Unit at UNIFESP: 12 years experience
-
Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort
-
Diagnostic value of olfactory dysfunction in Parkinson’s disease
-
Diagnostic value of vagus nerve ultrasound in Parkinson’s disease
-
Dietary and Plasma Polyunsaturated Fatty Acids in Parkinson’s Disease
-
Dietary insights of Parkinson’s Disease patients
-
Difference in distribution between alpha-synuclein oligomers and Lewy bodies in Parkinson’s disease brain
-
Difference in olfactory impairment between tremor dominant and akinetic rigid dominant Parkinson’s disease patients
-
Difference in pallidal single unit activity in cervical dystonia with jerky and sinusoidal head tremor
-
Differences in subthalamic oscillatory neuronal activity associated with severity in Parkinson’s disease
-
Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US
-
Differential Diagnosis Between Functional Facial Spasm and Hemifacial Spasm: Role of Blink Reflex
-
Differential Effect of Dorsal and Ventral STN Stimulation on Perseveration and Evidence Accumulation
-
Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition
-
Differential patterns of gray matter volume in responders and non-responders with Parkinson’s disease after deep brain stimulation
-
Differentiating Parkinson’s disease dementia and mild cognitive impairment from idiopathic Parkinson’s disease using machine learning approach
-
Diffusion Magnetic Resonance Imaging with Neurite Orientation and Dispersion Imaging (NODDI) Detects Early Localized Cortex Disruption in Parkinson’s Disease
-
Direct Targeting of the VIM Nucleus during High Intensity Focused Ultrasound (HIFU) by Direct Visualization
-
Directional programming in GPi-DBS for Parkinson’s disease and retrospective assessment of UPDRS III outcomes: First clinical case series
-
Directional versus conventional subthalamic deep brain stimulation for advanced Parkinson’s disease: Short-term outcomes of a pilot study
-
Directional versus Omnidirectional Deep Brain Stimulation: Results of a Multicenter Prospective Blinded Crossover Study
-
Discharge rate dependency of bursting of pallidal neurons underlying choreic movements
-
Disconnected brain in functional movement disorders with anxious & depressive symptoms
-
Discriminating Essential and Dystonic Tremor using Video-based Time Series Analysis
-
Discrimination of alpha-synuclein strains and sub-strains in Synucleinopathies
-
Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease
-
Disease stage and UMSARS progression: Implications for clinical trials
-
Disentangling postural instability-gait difficulties classification model for the prediction of cognitive impairment in de novo Parkinson’s Disease patients
-
Disparities in access to care and research participation among individuals with advanced Parkinson’s Disease: Comparison of participants in a home visit model vs. national registry
-
Disrupted functional brain connectome at the early non-freezing stage of Parkinson’s disease patients with freezing of gait
-
Distinct compensatory and maladaptive wiring patterns in genotypic Parkinson’s disease
-
Distinct maladaptive and compensatory wiring patterns in penetrant and non-penetrant dystonia mutation carriers
-
Distribution of intranasal hNSCs in a mouse model of MPTP-induced Parkinson’s disease
-
Diverse Phenotypic Variations Among Siblings with NBIA: A Case Report and Review of Literature
-
DJ1 and α-Synuclein as CSF biomarkers and gene polymorphisms: association with clinical parameters in Parkinson’s disease
-
Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease
-
Do improvements to primary symptoms from sensory training differ in Parkinson’s disease ON vs. OFF dopaminergic medications?
-
Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries
-
Does age at onset of Parkinson’s disease affect the development of dementia?
-
Does constipation predict cognitive impairment and dementia in de novo Parkinson’s disease patients? A multi-cohort longitudinal data analysis
-
Donepezil for mild cognitive impairment in Parkinson’s disease: A 48-week follow-up study
-
Dopaminergic denervation in de-novo Parkinson’s disease. Does functional somatotopy plays a role?
-
Dose Optimization of Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients with Parkinson’s Disease: Clinical and Exposure Response Findings
-
Downbeat nystagmus and progressive ataxia mimicking a neurodegenerative disease: a specific phenotype of Chiari malformation
-
Driving in Parkinson’s Disease: A Retrospective Study of Driving and Mobility Assessments
-
Driving motor rhythms modulates bradykinesia and cortical excitability in Parkinson’s disease
-
Dry Eye and Parkinson’s Disease: A Literature Review
-
Dual hit model of Parkinson’s disease propagation using MRI biomarkers and partial least squares path modeling
-
Duration of Effect of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-naïve Subjects: Results from a Phase III Study
-
Dysfunction in superior frontal gyrus associated with diphasic dyskinesia in Parkinson’s disease
-
Dyskinesia and bradykinesia severity patterns in Parkinson’s disease using a wearable sensor
-
Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration
-
DystoniaNet: Neural Biomarker-Based Platform for Dystonia Diagnosis using Deep Learning
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org